The UCHTC provides clinical care for patients with various bleeding and clotting disorders, maintains a pharmacy of cutting edge treatments specific to these disorders and conducts research to develop new treatments for bleeding patients around the world.
Hemophilia is the name for a group of hereditary genetic disorders that impair a sufferer’s ability to form blood clots after an injury to a vein. A person with hemophilia, or one of several related bleeding disorders, can experience a serious internal bleed from a seemingly minor injury or, in the case of severe hemophilia, after seemingly no injury at all. To learn more about hemophilia, click HERE.
Thrombophilia, or hypercoagulability, is a disorder that causes patients’ blood to clot more than normal. Sufferers of thrombophilia can form blood clots in their veins even when there is no damage or injury, which can contribute to serious health problems like difficulty breathing, strain on the heart and even stroke. To learn more about thrombosis, click HERE.
A stroke or "brain attack" occurs when a blood clot blocks an artery (a blood vessel that carries blood from the heart to the body) or a blood vessel (a tube through which the blood moves through the body) breaks, interrupting blood flow to an area of the brain. When either of these things happen, brain cells begin to die and brain damage occurs. To learn more about stroke, click HERE.